On the public citation graph

Pharmacological repression of PPARγ promotes osteogenesis

https://doi.org/10.1038/ncomms8443
0 signed · 162 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s13361-012-0419-6openalex-snapshot
HDX Workbench: Software for the Analysis of H/D Exchange MS Data
inferredcites →https://doi.org/10.1016/j.bcp.2006.03.023openalex-snapshot
Antagonism of peroxisome proliferator-activated receptor γ prevents high-fat diet-induced obesity in vivo
inferredcites →https://doi.org/10.1016/j.biochi.2005.02.002openalex-snapshot
The conserved residue Phe273(282) of PPARα(γ), beyond the ligand-binding site, functions in binding affinity through solvation effect
inferredcites →https://doi.org/10.1016/j.bmc.2012.11.058openalex-snapshot
Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity
inferredcites →https://doi.org/10.1016/j.cellsig.2009.08.003openalex-snapshot
Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR
inferredcites →https://doi.org/10.1016/j.cmet.2014.01.021openalex-snapshot
PPARγ in Vagal Neurons Regulates High-Fat Diet Induced Thermogenesis
inferredcites →https://doi.org/10.1016/j.molcel.2010.07.022openalex-snapshot
Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic Acid
inferredcites →https://doi.org/10.1016/j.str.2007.07.014openalex-snapshot
Partial Agonists Activate PPARγ Using a Helix 12 Independent Mechanism
inferredcites →https://doi.org/10.1016/s0076-6879(97)76066-xopenalex-snapshot
[20] Processing of X-ray diffraction data collected in oscillation mode
inferredcites →https://doi.org/10.1016/s0092-8674(00)81717-1openalex-snapshot
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
inferredcites →https://doi.org/10.1016/s1097-2765(01)00353-7openalex-snapshot
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
inferredcites →https://doi.org/10.1021/ac051294fopenalex-snapshot
Probing Protein Ligand Interactions by Automated Hydrogen/Deuterium Exchange Mass Spectrometry
inferredcites →https://doi.org/10.1038/nature09291openalex-snapshot
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
inferredcites →https://doi.org/10.1038/nature10383openalex-snapshot
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
inferredcites →https://doi.org/10.1038/ncomms4571openalex-snapshot
An alternate binding site for PPARγ ligands
inferredcites →https://doi.org/10.1038/nm.2349openalex-snapshot
A role for central nervous system PPAR-γ in the regulation of energy balance
inferredcites →https://doi.org/10.1038/nsmb.1474openalex-snapshot
Structural basis for the activation of PPARγ by oxidized fatty acids
inferredcites →https://doi.org/10.1038/sj.bjp.0705973openalex-snapshot
GW9662, an antagonist of PPAR-gamma, inhibits breast tumour cell growth and promotes the anticancer effects of the PPAR-gamma agonist Rosiglitazone, independently of PPAR-gamma activation.
inferredcites →https://doi.org/10.1073/pnas.0914360107openalex-snapshot
Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy
inferredcites →https://doi.org/10.1074/jbc.c800139200openalex-snapshot
A Functional Peroxisome Proliferator-activated Receptor-γ Ligand-binding Domain Is Not Required for Adipogenesis
inferredcites →https://doi.org/10.1107/s0907444904019158openalex-snapshot
Coot : model-building tools for molecular graphics
inferredcites →https://doi.org/10.1111/j.1463-1326.2010.01225.xopenalex-snapshot
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
inferredcites →https://doi.org/10.1126/stke.2002.121.pe9openalex-snapshot
The Dawn of the SPPARMs?
inferredcites →https://doi.org/10.1152/ajpendo.00312.2002openalex-snapshot
Effect of heterozygous PPARγ deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding
inferredcites →https://doi.org/10.1155/2008/494161openalex-snapshot
Potential of Peroxisome Proliferator‐Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types
inferredcites →https://doi.org/10.1172/jci19900openalex-snapshot
PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
inferredcites →https://doi.org/10.1172/jci8538openalex-snapshot
Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
inferredcites →https://doi.org/10.1634/stemcells.19-5-408openalex-snapshot
MicroSAGE Analysis of 2,353 Expressed Genes in a Single Cell‐Derived Colony of Undifferentiated Human Mesenchymal Stem Cells Reveals mRNAs of Multiple Cell Lineages
inferredcites →https://doi.org/10.2210/pdb2vv1/pdbopenalex-snapshot
hPPARgamma Ligand binding domain in complex with 4-HDHA
inferredcites →https://doi.org/10.2337/db06-1734openalex-snapshot
S 26948
inferredcites →https://doi.org/10.3945/ajcn.2009.28449eopenalex-snapshot
Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4782907openalex-extracted
Comparative Molecular Simulation of Pparg Protein Interactions with Omega-3 and Omega-6 Lipid Mediators
inferred← citeshttps://doi.org/10.1002/adtp.202400400openalex-snapshot
Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics
inferred← citeshttps://doi.org/10.1002/ajoc.201800668openalex-snapshot
Rational Design and Synthesis of Reversible Covalent PPARγ Antagonistic Ligands Inhibiting Ser273 Phosphorylation
inferred← citeshttps://doi.org/10.1002/chem.201903404openalex-snapshot
π‐Hole Interactions Involving Nitro Aromatic Ligands in Protein Structures
inferred← citeshttps://doi.org/10.1002/mco2.650openalex-snapshot
Identification of an alternative ligand‐binding pocket in peroxisome proliferator‐activated receptor gamma and its correlated selective agonist for promoting beige adipocyte differentiation
inferred← citeshttps://doi.org/10.1002/med.21648openalex-snapshot
Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer
inferred← citeshttps://doi.org/10.1002/ptr.7912openalex-snapshot
Bavachinin selectively modulates PPAR γ and maintains bone homeostasis in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1002/stem.2645openalex-snapshot
IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution
inferred← citeshttps://doi.org/10.1007/978-1-4939-9195-2_21openalex-snapshot
Obtaining Crystals of PPARγ Ligand Binding Domain Bound to Small Molecules
inferred← citeshttps://doi.org/10.1007/978-1-4939-9195-2_22openalex-snapshot
Molecular Modeling Approach to Study the PPARγ–Ligand Interactions
inferred← citeshttps://doi.org/10.1007/978-3-319-45084-1_11openalex-snapshot
Osteoporosis in Patients with Peripheral Neuropathies
inferred← citeshttps://doi.org/10.1007/s00011-024-01929-xopenalex-snapshot
Rosiglitazone attenuates Acute Kidney Injury from hepatic ischemia–reperfusion in mice by inhibiting arachidonic acid metabolism through the PPAR-γ/NF-κB pathway
inferred← citeshttps://doi.org/10.1007/s00109-021-02164-1openalex-snapshot
Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events
inferred← citeshttps://doi.org/10.1007/s00198-016-3598-3openalex-snapshot
Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice
inferred← citeshttps://doi.org/10.1007/s00382-017-3759-xopenalex-snapshot
Western US high June 2015 temperatures and their relation to global warming and soil moisture
inferred← citeshttps://doi.org/10.1007/s00441-018-2976-xopenalex-snapshot
Sialoglycoprotein isolated from Carassius auratus eggs promotes osteogenesis by stimulating mesenchymal stem cells to commit to osteoblast differentiation
inferred← citeshttps://doi.org/10.1007/s11030-025-11118-5openalex-snapshot
PPARγ modulator predictor (PGMP_v1): chemical space exploration and computational insights for enhanced type 2 diabetes mellitus management
inferred← citeshttps://doi.org/10.1007/s11914-018-0426-zopenalex-snapshot
Marrow Fat—a New Target to Treat Bone Diseases?
inferred← citeshttps://doi.org/10.1007/s12010-022-04190-2openalex-snapshot
Identification of Selective PPAR-γ Modulators by Combining Pharmacophore Modeling, Molecular Docking, and Adipogenesis Assay
inferred← citeshttps://doi.org/10.1016/j.bcp.2019.113693openalex-snapshot
Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121066openalex-snapshot
Xenoextracellular matrix-rosiglitazone complex-mediated immune evasion promotes xenogenic bioengineered root regeneration by altering M1/M2 macrophage polarization
inferred← citeshttps://doi.org/10.1016/j.bmc.2019.115082openalex-snapshot
Structure optimization of a new class of PPARγ antagonists
inferred← citeshttps://doi.org/10.1016/j.bmc.2022.117130openalex-snapshot
Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists
inferred← citeshttps://doi.org/10.1016/j.bmc.2025.118393openalex-snapshot
Decades old glitazones still find niche in drug discoveries as PPAR-γ agonists: medicinal chemistry perspective, structure-activity relationships and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.bmcl.2019.126664openalex-snapshot
Design, synthesis, and evaluation of potent novel peroxisome proliferator-activated receptor γ indole partial agonists
inferred← citeshttps://doi.org/10.1016/j.bone.2025.117651openalex-snapshot
Prospective evidence for the gut–bone axis in osteoporotic fractures: Insights from genetic prediction and metabolite mediators
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.01.013openalex-snapshot
PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.108768openalex-snapshot
CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.107495openalex-snapshot
Mechanisms of Nelumbinis folium targeting PPARγ for weight management: A molecular docking and molecular dynamics simulations study
inferred← citeshttps://doi.org/10.1016/j.coph.2017.04.001openalex-snapshot
Cell–cell communication in bone development and whole-body homeostasis and pharmacological avenues for bone disorders
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.02.003openalex-snapshot
The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis
inferred← citeshttps://doi.org/10.1016/j.ebiom.2016.06.040openalex-snapshot
PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.05.012openalex-snapshot
An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117657openalex-snapshot
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174609openalex-snapshot
Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats
inferred← citeshttps://doi.org/10.1016/j.exger.2023.112281openalex-snapshot
The effects of PPARγ inhibitor on bones and bone marrow fat in aged glucocorticoid-treated female rats
inferred← citeshttps://doi.org/10.1016/j.fct.2017.12.009openalex-snapshot
Molecular determinants of PPARγ partial agonism and related in silico/in vivo studies of natural saponins as potential type 2 diabetes modulators
inferred← citeshttps://doi.org/10.1016/j.gendis.2018.05.004openalex-snapshot
CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss
inferred← citeshttps://doi.org/10.1016/j.gendis.2023.101122openalex-snapshot
The role of lipid metabolism in osteoporosis: Clinical implication and cellular mechanism
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.127042openalex-snapshot
The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review
inferred← citeshttps://doi.org/10.1016/j.isci.2018.06.012openalex-snapshot
PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
inferred← citeshttps://doi.org/10.1016/j.jbc.2021.101030openalex-snapshot
The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102539openalex-snapshot
Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARγ by inverse agonists
inferred← citeshttps://doi.org/10.1016/j.jbspin.2026.106096openalex-snapshot
Single-cell transcriptomics identifies CD36 as a negative regulator of osteogenic differentiation in murine osteoporosis
inferred← citeshttps://doi.org/10.1016/j.metabol.2024.156097openalex-snapshot
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation
inferred← citeshttps://doi.org/10.1016/j.namjnl.2026.100077openalex-snapshot
New Approach Methodologies (NAMs) to assess thyroid endocrine disruption-mediated cardiovascular outcomes: an example focused on the emerging contaminant octylmethoxycinnamate
inferred← citeshttps://doi.org/10.1016/j.nexres.2026.102525openalex-snapshot
Targeting PPARγ beyond classical agonism: Context-dependent signaling, post-translational regulation, and precision therapeutic opportunities
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.10.024openalex-snapshot
Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma
inferred← citeshttps://doi.org/10.1016/j.str.2018.07.007openalex-snapshot
Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism
inferred← citeshttps://doi.org/10.1016/j.str.2018.10.002openalex-snapshot
Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1
inferred← citeshttps://doi.org/10.1016/j.taap.2017.05.019openalex-snapshot
Methylparaben and butylparaben alter multipotent mesenchymal stem cell fates towards adipocyte lineage
inferred← citeshttps://doi.org/10.1016/j.xcrp.2023.101466openalex-snapshot
Discriminating functional and non-functional nuclear-receptor ligands with a conformational selection-inspired machine learning algorithm
inferred← citeshttps://doi.org/10.1021/acs.chemrestox.9b00498openalex-snapshot
Applicability Domains Enhance Application of PPARγ Agonist Classifiers Trained by Drug-like Compounds to Environmental Chemicals
inferred← citeshttps://doi.org/10.1021/acs.est.0c02639openalex-snapshot
Structures of Endocrine-Disrupting Chemicals Determine Binding to and Activation of the Estrogen Receptor α and Androgen Receptor
inferred← citeshttps://doi.org/10.1021/acs.est.1c04997openalex-snapshot
Structures of Endocrine-Disrupting Chemicals Correlate with the Activation of 12 Classic Nuclear Receptors
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00851openalex-snapshot
Determination of Molecule Category of Ligands Targeting the Ligand-Binding Pocket of Nuclear Receptors with Structural Elucidation and Machine Learning
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01379openalex-snapshot
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01218openalex-snapshot
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01377openalex-snapshot
Discovery of Novel Neo-Clerodane Derivatives as Potent Dual-Functional Antiosteoporosis Agents through Targeting Peroxisome Proliferator-Activated Receptor-γ
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00673openalex-snapshot
Inverse Agonists of Peroxisome Proliferator-Activated Receptor Gamma: Advances and Prospects in Cancer Treatment
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02192openalex-snapshot
A New Era for PPARγ: Covalent Ligands and Therapeutic Applications
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b01573openalex-snapshot
Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone
inferred← citeshttps://doi.org/10.1021/acschembio.2c00917openalex-snapshot
PPARγ Corepression Involves Alternate Ligand Conformation and Inflation of H12 Ensembles
inferred← citeshttps://doi.org/10.1021/acschembio.5b00580openalex-snapshot
SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial Agonism
inferred← citeshttps://doi.org/10.1021/acschembio.5b00899openalex-snapshot
Synthetic RORγt Agonists Enhance Protective Immunity
inferred← citeshttps://doi.org/10.1021/acschembio.5c00081openalex-snapshot
Discovery of Chemical Tools for Polysorbate-Degradative Enzyme Control in the Biopharmaceutical Upstream Process via Multi-Omic Profiling of Host Cell Clones
inferred← citeshttps://doi.org/10.1021/acschembio.6b01015openalex-snapshot
Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor
inferred← citeshttps://doi.org/10.1021/jacs.5c13803openalex-snapshot
De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI Inhibitors
inferred← citeshttps://doi.org/10.1038/cddis.2016.9openalex-snapshot
PER1 prevents excessive innate immune response during endotoxin-induced liver injury through regulation of macrophage recruitment in mice
inferred← citeshttps://doi.org/10.1038/s41401-021-00756-8openalex-snapshot
The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.
inferred← citeshttps://doi.org/10.1038/s41418-017-0004-4openalex-snapshot
Basal p53 expression is indispensable for mesenchymal stem cell integrity
inferred← citeshttps://doi.org/10.1038/s41467-018-04176-xopenalex-snapshot
Defining a conformational ensemble that directs activation of PPARγ
inferred← citeshttps://doi.org/10.1038/s41467-018-07133-wopenalex-snapshot
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
inferred← citeshttps://doi.org/10.1038/s41467-019-13768-0openalex-snapshot
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
inferred← citeshttps://doi.org/10.1038/s41467-020-14750-xopenalex-snapshot
A molecular switch regulating transcriptional repression and activation of PPARγ
inferred← citeshttps://doi.org/10.1038/s41467-025-67608-5openalex-snapshot
Structural determinants of non-covalent PPARγ inverse agonism and their therapeutic implications
inferred← citeshttps://doi.org/10.1038/s41581-020-00339-6openalex-snapshot
Nuclear receptors in podocyte biology and glomerular disease
inferred← citeshttps://doi.org/10.1038/s41598-017-05666-6openalex-snapshot
Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis
inferred← citeshttps://doi.org/10.1038/s41598-021-86147-9openalex-snapshot
Chondrogenic and BMP-4 primings confer osteogenesis potential to human cord blood mesenchymal stromal cells delivered with biphasic calcium phosphate ceramics
inferred← citeshttps://doi.org/10.1038/s41598-023-37260-4openalex-snapshot
Transcriptome changes during osteogenesis of porcine mesenchymal stem cells derived from different types of synovial membranes and genetic background
inferred← citeshttps://doi.org/10.1038/srep41487openalex-snapshot
Identification of a novel selective PPARγ ligand with a unique binding mode and improved therapeutic profile in vitro
inferred← citeshttps://doi.org/10.1039/c6sc01279eopenalex-snapshot
Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands
inferred← citeshttps://doi.org/10.1042/bst20200005openalex-snapshot
Advances in the occurrence and biotherapy of osteoporosis
inferred← citeshttps://doi.org/10.1073/pnas.1717776115openalex-snapshot
Noncanonical agonist PPARγ ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy
inferred← citeshttps://doi.org/10.1073/pnas.1909016116openalex-snapshot
Quantitative structural assessment of graded receptor agonism
inferred← citeshttps://doi.org/10.1074/mcp.ra117.000308openalex-snapshot
Unique Interactome Network Signatures for Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Modulation by Functional Selective Ligands
inferred← citeshttps://doi.org/10.1080/07391102.2016.1151830openalex-snapshot
PPARγ non-covalent antagonists exhibit mutable binding modes with a similar free energy of binding: a case study
inferred← citeshttps://doi.org/10.1080/14728222.2020.1726889openalex-snapshot
Emerging therapeutic targets for osteoporosis
inferred← citeshttps://doi.org/10.1089/ten.tea.2016.0308openalex-snapshot
Enhanced Mandibular Bone Repair by Combined Treatment of Bone Morphogenetic Protein 2 and Small-Molecule Phenamil
inferred← citeshttps://doi.org/10.1101/2020.06.03.129668openalex-snapshot
CRTC1-MAML2 Establishes a PGC1α-IGF1 Circuit that Confers Vulnerability to PPARγ Inhibition
inferred← citeshttps://doi.org/10.1101/2025.05.08.652848openalex-snapshot
Discovery and characterization of FX-909, a covalent inverse agonist of PPARG rationally designed to impose a powerful repressive bias in PPARG for the treatment of PPARG/RXRA-activated muscle-invasive urothelial cancers
inferred← citeshttps://doi.org/10.1101/252817openalex-snapshot
Cooperative Cobinding of Synthetic and Natural Ligands to the Nuclear Receptor PPARγ
inferred← citeshttps://doi.org/10.1111/jcpe.12891openalex-snapshot
Peroxisome proliferator‐activated receptor γ plays dual roles on experimental periodontitis in rats
inferred← citeshttps://doi.org/10.1111/nyas.13999openalex-snapshot
Physiologic and pathologic effects of dietary free fatty acids on cells of the joint
inferred← citeshttps://doi.org/10.1124/pharmrev.121.000436openalex-snapshot
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
inferred← citeshttps://doi.org/10.1155/2015/254560openalex-snapshot
Identification of Bexarotene as a PPAR γ Antagonist with HDX
inferred← citeshttps://doi.org/10.1155/2020/9657380openalex-snapshot
The PPARΩPocket: Renewed Opportunities for Drug Development
inferred← citeshttps://doi.org/10.1158/0008-5472.can-17-1701openalex-snapshot
Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer
inferred← citeshttps://doi.org/10.1161/circresaha.119.316339openalex-snapshot
PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension
inferred← citeshttps://doi.org/10.1172/jci125915openalex-snapshot
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
inferred← citeshttps://doi.org/10.1172/jci90327openalex-snapshot
Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription
inferred← citeshttps://doi.org/10.1186/s12964-024-02025-7openalex-snapshot
Role of sirtuins in obesity and osteoporosis: molecular mechanisms and therapeutic targets
inferred← citeshttps://doi.org/10.1186/s13062-024-00581-zopenalex-snapshot
Integrative in-silico and in-vitro analysis of taurine and vitamin B12 in modulating PPARγ and Wnt signaling in hyperhomocysteinemia-induced osteoporosis
inferred← citeshttps://doi.org/10.1186/s13287-020-01631-9openalex-snapshot
LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
inferred← citeshttps://doi.org/10.1248/bpb.b21-00263openalex-snapshot
Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications
inferred← citeshttps://doi.org/10.1289/ehp4918openalex-snapshot
Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States)
inferred← citeshttps://doi.org/10.18632/oncotarget.6923openalex-snapshot
Core level regulatory network of osteoblast as molecular mechanism for osteoporosis and treatment
inferred← citeshttps://doi.org/10.2337/db17-0116openalex-snapshot
Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression
inferred← citeshttps://doi.org/10.3389/fendo.2019.00159openalex-snapshot
Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation Assessed by Proton MR Spectroscopy
inferred← citeshttps://doi.org/10.3390/biom13040694openalex-snapshot
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition
inferred← citeshttps://doi.org/10.3390/ijms18010015openalex-snapshot
CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands
inferred← citeshttps://doi.org/10.3390/medsci14010041openalex-snapshot
In Silico Investigation Reveals IL-6 as a Key Target of Asiatic Acid in Osteoporosis: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
inferred← citeshttps://doi.org/10.3390/toxics9030059openalex-snapshot
Novel QSAR Models for Molecular Initiating Event Modeling in Two Intersecting Adverse Outcome Pathways Based Pulmonary Fibrosis Prediction for Biocidal Mixtures
inferred← citeshttps://doi.org/10.3892/mmr.2019.9980openalex-snapshot
Inhibition of CXCR4 inhibits the proliferation and osteogenic potential of fibroblasts from ankylosing spondylitis via the Wnt/β‑catenin pathway
inferred← citeshttps://doi.org/10.55544/jrasb.1.5.1openalex-snapshot
Article Review: Biochemical Aspect of Survivin Hormone
inferred← citeshttps://doi.org/10.6026/97320630019633openalex-snapshot
Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management
inferred← citeshttps://doi.org/10.6084/m9.figshare.12033009openalex-snapshot
Additional file 1 of LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
inferred← citeshttps://doi.org/10.6084/m9.figshare.12033015openalex-snapshot
Additional file 2 of LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
inferred← citeshttps://doi.org/10.6084/m9.figshare.12033021openalex-snapshot
Additional file 3 of LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
inferred← citeshttps://doi.org/10.6084/m9.figshare.12033027openalex-snapshot
Additional file 4 of LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
inferred← citeshttps://doi.org/10.64898/2026.02.04.703935openalex-snapshot
Dexamethasone-induced PPARG expression in osteogenic differentiation in vitro: impact on SOX9 and RUNX2 levels
inferred← citeshttps://doi.org/10.70675/99f394a9zdd8bz4cb8z8348z6ada0a583d32openalex-snapshot
Mécanisme moléculaires du rôle protumorigénique de PPARgamma et RXRalpha dans les cancers de vessie
inferred← citeshttps://doi.org/10.7150/ijms.16484openalex-snapshot
Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling
inferred← citeshttps://doi.org/10.7554/elife.106697openalex-snapshot
Shifting the PPARγ conformational ensemble toward a transcriptionally repressive state improves covalent inhibitor efficacy
inferred← citeshttps://doi.org/10.7554/elife.106697.1openalex-snapshot
Shifting the PPARγ conformational ensemble towards a transcriptionally repressive state improves covalent inhibitor efficacy
inferred← citeshttps://doi.org/10.7554/elife.106697.2openalex-snapshot
Shifting the PPARγ conformational ensemble towards a transcriptionally repressive state improves covalent inhibitor efficacy
inferred← citeshttps://doi.org/10.7554/elife.43320openalex-snapshot
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.
inferred← citeshttps://doi.org/10.7554/elife.99782openalex-snapshot
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ
inferred← citeshttps://doi.org/10.7554/elife.99782.1openalex-snapshot
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ
inferred← citeshttps://doi.org/10.7554/elife.99782.2openalex-snapshot
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ
inferred← citeshttps://doi.org/10.7554/elife.99782.3openalex-snapshot
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.